Act for the Development of Biotech and Pharmaceutical Industry Article 12

Research personnel in public schools at the junior college level and above or public research institutions (organizations) that provide key technologies to start-up Biotech and Pharmaceutical Companies shall not be subject to Article 34 of the Act of Governing the Appointment of Educators and Paragraph 1, Article 13 of the Civil Servants Work Act, which prohibit business operation and limit the total shares held in a business to ten percent (10%), or Article 13 Paragraph 2, and Article 14 of the Civil Servants Work Act, which restrict research personnel from holding other positions concurrently. Nevertheless, relevant provisions under the Act on Recusal of Public Servants Due to Conflict of Interest shall still apply.A start-up Biotech and Pharmaceutical Company referred to in the preceding paragraph is a Biotech and Pharmaceutical Company incorporated and registered within eight (8) years.The determination of research personnel in public schools at the junior college level and above or public research institutions (organizations) as described in Paragraph 1, the types and number of jobs that research personnel may concurrently hold, the percentage of investment in the form of technology know-how as capital, disclosure of relevant information on business operation, recusal due to conflict of interest, supervision, audit, and other matters to be observed shall be prescribed by the Executive Yuan in conjunction with the Examination Yuan.
中文原文 生技新藥產業發展條例第12條
新創之生技醫藥公司,其主要技術提供者為公立專科以上學校或公立研究機關(構)研究人員者,不受教育人員任用條例第三十四條、公務員服務法第十三條第一項不得經營商業、股本總額百分之十、第二項及第十四條兼任他項業務之限制。
惟應遵守公職人員利益衝突迴避法相關規定。
前項所稱新創之生技醫藥公司,指自設立登記日起未滿八年者。
第一項公立專科以上學校或公立研究機關(構)從事研究人員之認定、得兼任職務與數額、技術作價投資比例之限制、經營商業之資訊公開、利益迴避、監督管理、查核及其他應遵行事項之辦法,由行政院會同考試院定之。

English translation for reference only; the Chinese text prevails. Not legal advice.